South Wales, Aug. 21 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "AIRNEXIS" on Aug. 11. The details about the trademark application no. UK00004429187 published in the journal no. 2026/034 (Aug. 21).
With Abion UK Limited as representative, AirNexis Therapeutics, Inc. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical preparations and drugs for the treatment, control, prevention, maintenance, and management of
inflammatory and respiratory diseases and symptoms in humans; anti-inflammatory and immunomodulatory
pharmaceutical compositions; medications for respiratory conditions including asthma, chronic obstructive pulmonary
disease (COPD), bronchitis, cystic fibrosis, pneumonia, allergic rhinitis, Idiopathic Pulmonary Fibrosis (IPF),
bronchiectasis, chronic cough and other pulmonary disorders; pharmaceutical compositions in the form of tablets,
capsules, liquids, aerosols, inhalers, creams, ointments, gels, and injectables; fixed-dose combination pharmaceutical
preparations for inflammatory and respiratory diseases and symptoms in humans; combination pharmaceutical
preparations comprising two or more active ingredients for inflammatory and respiratory diseases and symptoms in
humans; pharmaceutical preparations for use in combination therapy for inflammatory and respiratory diseases and
symptoms in humans.
Class 44 : Research, development, and formulation of pharmaceuticals for inflammatory and respiratory diseases; pharmaceutical
formulation services in the field of inflammatory and respiratory diseases.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004429187
Disclaimer: Curated by HT Syndication.
